KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in Net LoansDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omega Healthcare Investors (OHI) Capital Expenditures (2016 - 2025)

Omega Healthcare Investors' Capital Expenditures history spans 14 years, with the latest figure at $2.1 million for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 78.22% year-over-year to $2.1 million; the TTM value through Dec 2025 reached $33.6 million, down 51.31%, while the annual FY2025 figure was $33.6 million, 51.31% down from the prior year.
  • Capital Expenditures for Q4 2025 was $2.1 million at Omega Healthcare Investors, up from -$1.5 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $45.3 million in Q3 2024 and bottomed at -$20.6 million in Q4 2022.
  • The 5-year median for Capital Expenditures is $10.6 million (2021), against an average of $10.5 million.
  • The largest annual shift saw Capital Expenditures crashed 228.75% in 2022 before it soared 2674.19% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $16.0 million in 2021, then plummeted by 228.75% to -$20.6 million in 2022, then soared by 174.92% to $15.4 million in 2023, then crashed by 37.2% to $9.7 million in 2024, then plummeted by 78.22% to $2.1 million in 2025.
  • Per Business Quant, the three most recent readings for OHI's Capital Expenditures are $2.1 million (Q4 2025), -$1.5 million (Q3 2025), and $12.8 million (Q2 2025).